Thursday, April 05, 2018
PITTSBURGH (April 5, 2018) — With a commitment to offering exceptional care close to home for those in central Pennsylvania, Highmark Health today announced a $25 million grant to support specialized cancer care and innovative research at Penn State Cancer Institute.
The grant will provide support for development of new cancer treatment drugs, clinical trials to test promising new therapies and recruitment of leading cancer researchers in key disciplines.
In December 2017, Highmark Health and Penn State Health announced a long-term partnership that includes a $1 billion joint investment to develop a high-value, community-based health care network designed to expand local access to primary and specialty care and enhance collaboration with community physicians.
"As we said last year, we believe very strongly in the team at Penn State and the clinical expertise at the Milton S. Hershey Medical Center," said David Holmberg, president and CEO, Highmark Health. "Today, through this $25 million investment in Penn State Cancer Institute, we are affirming our commitment to a collaboration between the two strongest health care brands in Pennsylvania who share a passion for providing our members and patients with unsurpassed service and quality."
Highmark's latest $25 million grant will allow the Cancer Institute to make immediate investments in research operations and transformative science. An area of emphasis will be developing research laboratory services through new shared scientific resources, which will be available to all Cancer Institute members. Examples include an Absorption, Distribution, Metabolism and Excretion laboratory — where the effects of potential new drugs can be studied — and a developmental therapeutics laboratory to develop and manage Phase 1 clinical trials.
"Penn State College of Medicine has a rich history in cancer research, from our work decades ago that contributed to the development of the world's first cervical cancer vaccine to the many vital studies underway today that are helping us to understand how different cancers form, spread and can be effectively prevented and treated," said Dr. A. Craig Hillemeier, dean, Penn State College of Medicine; chief executive officer, Penn State Health; and senior vice president for health affairs, Penn State. "This grant is a demonstration of Highmark's confidence in our ability to continue to advance discoveries that improve the lives of people with cancer."
Based on the Penn State Health Milton S. Hershey Medical Center campus, Penn State Cancer Institute is the region's leading cancer care provider. Clinical services are offered in Hershey and at two other locations in central Pennsylvania — State College, Pa., through a partnership with Mount Nittany Health, and Reading, Pa., at Penn State Health St. Joseph. With a research presence in Hershey and at the University Park campus, the Cancer Institute is the centerpiece of Penn State's commitment to discoveries that will lead to the prevention, treatment and cures for cancer.
"Penn State is among the leading research universities in the world, and we are committed to using that work to improve the lives of people across the region who are suffering from chronic and life-threatening conditions," said Penn State President Eric Barron. "We are very grateful that Highmark is partnering with us in the fight to conquer cancer and to invest in the future of health care."
One of Penn State Cancer Institute's greatest needs is recruiting highly trained personnel to assist in project management and protocol development for translational research and clinical trials. The grant funds also will support clinical researchers developing investigator-initiated trials, enabling "Highmark Scholars" to bring their research ideas into the clinic. This will allow people with cancer in central Pennsylvania, including Highmark members, the opportunity to take part in original clinical trials without traveling far from home.
"This grant will help us continue to pursue the best scientists in the world to be part of the Penn State Cancer Institute team," said Dr. Raymond J. Hohl, director, Penn State Cancer Institute. "This means we improve our knowledge about the disease, and that ultimately benefits our patients."
The grant announcement follows other recent developments that demonstrate Penn State Health's leadership in providing comprehensive cancer care in central Pennsylvania. Yesterday (April 4), Penn State Health St. Joseph announced the expansion of its Medical Office Building in Bern Township to incorporate a new linear accelerator to treat solid tumor cancers. On April 2, Penn State Health announced development of a new Department of Radiation Oncology at Penn State College of Medicine, a move also designed to enhance recruitment of the best minds in cancer treatment and research, and trainees that will become tomorrow's cancer care providers.
"I am so pleased that Highmark is part of this innovative provider-payor collaboration, which is going to change and improve lives," said Deborah Rice-Johnson, president, Highmark Inc. "This type of financial commitment also provides significant stability for Penn State Cancer Institute and helps ensure that our members and everyone in the community will continue to have access to high-quality, affordable care."
Rice also said keeping cancer care for patients close to their home, families and support system can't be emphasized enough. She added that it is one of the great benefits of these types of provider partnerships that have resulted from the Highmark and Penn State collaboration.
Penn State Health is a multi-hospital health system serving patients and communities across 29 counties in central Pennsylvania. It employs more than 13,000 people systemwide. The system includes Penn State Health Milton S. Hershey Medical Center, Penn State Children's Hospital, and Penn State Cancer Institute based in Hershey, Pa.; Penn State Health St. Joseph Medical Center in Reading, Pa.; and more than 1,400 physicians and direct care providers at 119 medical office locations. Additionally, the system jointly operates various health care providers, including Penn State Health Rehabilitation Hospital, Hershey Outpatient Surgery Center, Hershey Endoscopy Center, Horizon Home Healthcare and Pennsylvania Psychiatric Institute. Penn State Health shares an integrated strategic plan and operations with Penn State College of Medicine, the University's medical school. With campuses in State College and Hershey, Pa., the College of Medicine boasts a portfolio of more than $100 million in funded research and more than 1,700 students and trainees in medicine, nursing, other health professions and biomedical research.
Highmark Health, a Pittsburgh, PA based enterprise that employs more than 40,000 people who serve millions of Americans across the country, is the second largest integrated health care delivery and financing network in the nation based on revenue. Highmark Health is the parent company of Highmark Inc., Allegheny Health Network, and HM Health Solutions. Highmark Inc. and its subsidiaries and affiliates provide health insurance to nearly 5 million members in Pennsylvania, West Virginia and Delaware as well as dental insurance, vision care and related health products through a national network of diversified businesses that include United Concordia Companies, HM Insurance Group, and Visionworks. Allegheny Health Network is the parent company of an integrated delivery network that includes eight hospitals, more than 2,800 affiliated physicians, ambulatory surgery centers, an employed physician organization, home and community-based health services, a research institute, a group purchasing organization, and health and wellness pavilions in western Pennsylvania. HM Health Solutions focuses on meeting the information technology platform and other business needs of the Highmark Health enterprise as well as unaffiliated health insurance plans by providing proven business processes, expert knowledge and integrated cloud-based platforms. To learn more, please visit www.highmarkhealth.org.
Penn State Health
Highmark is a registered mark of Highmark Inc. © 2022 Highmark Inc., All Rights Reserved.
Highmark Blue Cross Blue Shield serves the 29 counties of western Pennsylvania and 13 counties of northeastern Pennsylvania. Highmark Blue Shield serves the 21 counties of central Pennsylvania and also provides services in conjunction with a separate health plan in southeastern Pennsylvania. Highmark Blue Cross Blue Shield West Virginia serves the state of West Virginia plus Washington County. Highmark Blue Cross Blue Shield Delaware serves the state of Delaware. Highmark Blue Cross Blue Shield of Western New York serves eight counties in Western New York and Highmark Blue Shield of Northeastern New York serves 13 counties in Northeastern New York. Each of these companies is an independent licensee of the Blue Cross Blue Shield Association. Blue Cross, Blue Shield and the Blue Cross and Blue Shield symbols are registered marks of the Blue Cross Blue Shield Association, an association of independent Blue Cross and Blue Shield companies.
This page is not available for this ZIP code. Please enter your ZIP code or return to highmark.com.